Beauty Health Company, popularly known by the ticker symbol SKIN, is a leading innovator in the aesthetic health and wellness industry based in Long Beach, California. SKIN is renowned for pioneering technological advancements in skincare and wellness solutions.
The company is the manufacturer behind the famous HydraFacial, a non-invasive skin treatment that cleanses, extracts and hydrates the skin. The treatment employs proprietary serums, infused with a mix of hydrating ingredients and antioxidants, which are tailored to each client's specific skincare needs. Unlike traditional facials, HydraFacial uses vacuum technology to deliver these serums, promoting a deeper absorption to enhance the overall skin health and aesthetics.
Beauty Health Co emphasizes a personalized approach to skincare, considering the unique characteristics and needs of every client's skin. Its flagship product, HydraFacial, is designed to be adaptable, accommodating different skin types and addressing a broad spectrum of skin concerns such as fine lines, wrinkles, skin tone unevenness, oily skin, and congested pores.
The company takes pride in its role as a change-maker in the skincare industry and it continues to push boundaries through enhancing the HydraFacial experience. It collaborates with top-notch research institutes and dermatologists to ensure scientific accuracy and effectiveness. As a result, it has managed to create a community of loyal clients globally, including skincare professionals and celebrities.
On the business side, Beauty Health Co went public through a merger with special-purpose acquisition corporation (SPAC) Vesper Healthcare Acquisition Corp in May 2021, listing on Nasdaq under the ticker symbol SKIN. The company has experienced tremendous and above average growth, which is attributed to its innovative products, excellent customer service, and effective growth strategies.
Beauty Health Co is guided by its mission to provide immediate and long-lasting skincare results to people all over the world. By offering deep skin health restoration and protection, the company holds true its belief that everyone deserves to feel good and confident in their own skin.
Staying true to its humanitarian values, the company also works to empower the people by providing education about skin health and self-care. Through its initiatives, SKIN is playing a significant role in shaping the skincare industry to be more inclusive, comprehensive, and efficient in addressing individual skincare needs and concerns.
In summary, Beauty Health Co (SKIN) is the hallmark of aesthetic beauty and wellness solutions distinguished by its innovative treatment, HydraFacial, and its commitment to providing personalized skincare treatments. The company continually invests in research and development to enhance the efficacy of its skincare treatments, maintain its market leadership, and ultimately, bolster the trust and loyalty of its consumer base.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
SkinHealth Systems Inc. (SKIN) shares jumped 9% after completing a 1-for-20 reverse stock split, which helped the company regain compliance with Nasdaq's minimum bid price requirement. Despite this surge, analysts note that the consensus EPS estimate for the upcoming quarter has remained unchanged, suggesting that sustained upward momentum might require positive revisions in earnings estimates. The stock currently holds a Zacks Rank #3 (Hold).
SkinHealth Systems (SKIN) announced that its board of directors has approved a 1-for-20 reverse stock split. The article indicates that further details are available for subscribers, implying that the reverse split aims to adjust the company's stock structure.
The Beauty Health Company (NASDAQ:SKIN) has an average "Hold" rating from seven analysts, with an average 12-month price target of $1.38. The company's shares opened at $0.63, near its 12-month low, and its recent earnings matched EPS expectations but missed revenue forecasts. Institutional investors own a significant portion of the company's stock.
The Beauty Health Company (NASDAQ:SKIN) has received a consensus "Hold" rating from seven analysts, with an average 12-month price target of $1.375. Despite recent reductions in outlook from some firms, Roth Capital reaffirmed a "buy" rating. The company's stock opened at $0.69, near its 52-week low, and reported quarterly revenue below expectations with a loss of $0.02 per share.
SkinHealth Systems Inc. announced that its SkinStylus microneedling device has received new FDA clearance for improving the appearance of periorbital wrinkles in adults aged 22 and older across all Fitzpatrick skin types. This expands the device's indications, reinforcing SkinHealth System’s commitment to science-backed innovation in medical aesthetics. The SkinStylus SteriLock MicroSystem, a Class II Medical Device, is also cleared for facial acne scars and surgical/traumatic hypertrophic scars on the abdomen.